Partnership to Support National Gastroenterology-Focused Clinical Registry

The GI Quality Improvement Consortium, Inc. (GIQuIC), a joint collaboration of the American College of Gastroenterology (ACG) and American Society of Gastrointestinal Endoscopy (ASGE), has launched a partnership with data and analytics technology company Health Catalyst to reduce data entry burden and simplify registry data management for GIQuIC’s national clinical registry.

According to the press release, GIQuiC offers the only national gastroenterology-focused clinical registry in the country. Through the new partnership, the organization will leverage ARMUS, part of Health Catalyst’s HYBRID Clinical Registry and Reporting solution, to streamline user experience, enhance data extraction and capture, and improve reporting.

"This collaboration will enhance the service we already provide to our registry participants by allowing GIQuIC to leverage the depth and breadth of offerings and prior experience and success Health Catalyst has with respect to registry services and healthcare analytics. The ultimate goal is to empower our users to improve the quality of the healthcare they provide to their patients," said Costas H. Kefalas, MD, president of the GIQuIC Board of Directors, in the press release. "This experience will be especially valuable as we enhance the registry functionality, add additional endoscopy procedures and digestive disease states, and facilitate patient-reported outcomes."

Using ARMUS, GIQuIC aims to improve efficiency and data quality while maintaining high-quality performance. Specifically, the press release indicates that GIQuIC will use the tool to reduce registry data entry burden and simplify registry data management to the point where existing registry operations for colonoscopy and esophagogastroduodenoscopy (EGD) procedures can be streamlined by the beginning of 2024.

Following this transition, the press release indicates that GIQuIC will increase data collection and reporting relative to certain endoscopic procedures and disease states, including inflammatory bowel disease (IBD), endoscopic bariatric therapy (EBT), endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), deep enteroscopy, and wireless capsule endoscopy.

Other healthcare organizations have also recently partnered with Health Catalyst to improve their data analytics capabilities.

In August, Tennessee-based LifePoint Health teamed up with the company to advance patient care, safety, and satisfaction while improving outcomes across the health system’s network.

The partnership enabled LifePoint to deploy Health Catalyst’s suite of data collection- and analytics-based patient care solutions. Using these solutions, the health system indicated that it aims to reduce variation in clinical outcomes for patients, improve the overall quality of care, and further advance LifePoint's data and analytics capabilities to support its National Quality Program.

In addition to bolstering the program, the partnership builds on LifePoint’s innovation strategy, known as LifePoint Forward, which focuses on enhancing the health system’s capacity to identify, invest in, and deploy solutions that improve access, quality, and patient outcomes while decreasing costs.